DK0686156T3 - Pyrazoltriaziner med inhiberende aktivitet over for interleukin-1 og tumornekrosefaktor - Google Patents

Pyrazoltriaziner med inhiberende aktivitet over for interleukin-1 og tumornekrosefaktor

Info

Publication number
DK0686156T3
DK0686156T3 DK94906381T DK94906381T DK0686156T3 DK 0686156 T3 DK0686156 T3 DK 0686156T3 DK 94906381 T DK94906381 T DK 94906381T DK 94906381 T DK94906381 T DK 94906381T DK 0686156 T3 DK0686156 T3 DK 0686156T3
Authority
DK
Denmark
Prior art keywords
alkyl
suitable substituent
pct
triazines
pyrazole
Prior art date
Application number
DK94906381T
Other languages
Danish (da)
English (en)
Inventor
Yoshio Kawai
Hitoshi Yamazaki
Hirokazu Tanaka
Teruo Oku
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of DK0686156T3 publication Critical patent/DK0686156T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK94906381T 1993-02-26 1994-02-09 Pyrazoltriaziner med inhiberende aktivitet over for interleukin-1 og tumornekrosefaktor DK0686156T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939303993A GB9303993D0 (en) 1993-02-26 1993-02-26 New heterocyclic derivatives
PCT/JP1994/000213 WO1994019350A1 (fr) 1993-02-26 1994-02-09 Pyrazolitriazines a activite inhibant l'interleukine-1 et le facteur de necrose tumorale

Publications (1)

Publication Number Publication Date
DK0686156T3 true DK0686156T3 (da) 2002-11-11

Family

ID=10731142

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94906381T DK0686156T3 (da) 1993-02-26 1994-02-09 Pyrazoltriaziner med inhiberende aktivitet over for interleukin-1 og tumornekrosefaktor

Country Status (20)

Country Link
US (1) US5670503A (fr)
EP (1) EP0686156B1 (fr)
JP (1) JP3569917B2 (fr)
KR (1) KR100313615B1 (fr)
CN (1) CN1041929C (fr)
AT (1) ATE220677T1 (fr)
AU (1) AU681625B2 (fr)
CA (1) CA2156919A1 (fr)
DE (1) DE69430988T2 (fr)
DK (1) DK0686156T3 (fr)
ES (1) ES2176235T3 (fr)
GB (1) GB9303993D0 (fr)
HU (1) HUT70832A (fr)
IL (1) IL108562A (fr)
MX (1) MX9401408A (fr)
PT (1) PT686156E (fr)
RU (1) RU2124517C1 (fr)
TW (1) TW260669B (fr)
WO (1) WO1994019350A1 (fr)
ZA (1) ZA94787B (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0913392B1 (fr) 1996-04-25 2003-07-02 Nissan Chemical Industries, Limited Derives ethyleniques et agents pesticides
AU7726898A (en) 1997-05-22 1998-12-11 G.D. Searle & Co. Pyrazole derivatives as p38 kinase inhibitors
US6979686B1 (en) 2001-12-07 2005-12-27 Pharmacia Corporation Substituted pyrazoles as p38 kinase inhibitors
US6514977B1 (en) 1997-05-22 2003-02-04 G.D. Searle & Company Substituted pyrazoles as p38 kinase inhibitors
CA2293436C (fr) 1997-06-12 2010-10-26 Rhone-Poulenc Rorer Limited Acetals cycliques imidazolyle
AU7966198A (en) 1997-06-13 1998-12-30 Smithkline Beecham Corporation Novel pyrazole and pyrazoline substituted compounds
CA2306811A1 (fr) 1997-10-14 1999-04-22 Yoshiyuki Aoki Composes de piperazine et utilisation medicale desdits composes
AR017219A1 (es) 1997-12-19 2001-08-22 Smithkline Beecham Corp Derivados de imidazol 1,4,5 sustituidos, composiciones que los comprenden, procedimiento para la preparacion de dichos derivados, uso de los derivados parala manufactura de un medicamento
US6858617B2 (en) 1998-05-26 2005-02-22 Smithkline Beecham Corporation Substituted imidazole compounds
WO2000010563A1 (fr) * 1998-08-20 2000-03-02 Smithkline Beecham Corporation Nouveaux composes de triazole substitues
ATE258055T1 (de) 1998-11-04 2004-02-15 Smithkline Beecham Corp Pyridin-4-yl oder pyrimidin-4-yl substituierte pyrazine
EP1208748A4 (fr) * 1999-08-31 2002-11-20 Fujisawa Pharmaceutical Co Conservateurs pour organes
US7253169B2 (en) 1999-11-12 2007-08-07 Gliamed, Inc. Aza compounds, pharmaceutical compositions and methods of use
US6417189B1 (en) * 1999-11-12 2002-07-09 Gpi Nil Holdings, Inc. AZA compounds, pharmaceutical compositions and methods of use
ES2249309T3 (es) 1999-11-23 2006-04-01 Smithkline Beecham Corp Compuestos de 3,4-dihidro-(1h)quinazolin-2-ona como inhibidores de csbp/p39 kinasa.
AU1783201A (en) 1999-11-23 2001-06-04 Smithkline Beecham Corporation 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
US6759410B1 (en) 1999-11-23 2004-07-06 Smithline Beecham Corporation 3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors
JP2003514899A (ja) 1999-11-23 2003-04-22 スミスクライン・ビーチャム・コーポレイション CSBP/p38キナーゼ阻害剤としての3,4‐ジヒドロ−(1H)−キナゾリン−2−オン化合物
US7235551B2 (en) 2000-03-02 2007-06-26 Smithkline Beecham Corporation 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
JP4524072B2 (ja) 2000-10-23 2010-08-11 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー 新規化合物
US6583143B2 (en) * 2000-12-28 2003-06-24 Neurocrine Biosciences, Inc. CRF receptor antagonists and methods relating thereto
DE60221392T2 (de) * 2001-05-24 2008-04-17 Eli Lilly And Co., Indianapolis Neue pyrrolderivate als pharmazeutische mittel
DE60315826T2 (de) 2002-04-19 2008-05-21 Smithkline Beecham Corp. Neue verbindungen
ES2278170T3 (es) 2002-07-09 2007-08-01 BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG Composiciones farmaceuticas de anticolinergicos e inhibidores de la quinasa p38 en el tratamiento de enfermedades respiratorias.
US7514441B2 (en) * 2002-08-26 2009-04-07 Takeda Pharmaceutical Company Limited Substituted pyrazolo [1,5-A]pyrimidines as calcium receptor modulating agents
AU2004210127B2 (en) * 2003-01-27 2009-10-01 Merck Sharp & Dohme Corp. Substituted pyrazoles, compositions containing such compounds and methods of use
DE602005006806D1 (de) * 2004-06-04 2008-06-26 Merck & Co Inc Pyrazolderivate, zusammensetzungen, die solche verbindungen enthalten, und anwendungsverfahren
US20060035893A1 (en) 2004-08-07 2006-02-16 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
PE20060777A1 (es) 2004-12-24 2006-10-06 Boehringer Ingelheim Int Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
PE20061351A1 (es) 2005-03-25 2007-01-14 Glaxo Group Ltd COMPUESTOS 8H-PIRIDO[2,3-d]PIRIMIDIN-7-ONA 2,4,8-TRISUSTITUIDOS COMO INHIBIDORES DE LA QUINASA CSBP/RK/p38
US20090137550A1 (en) 2005-03-25 2009-05-28 Glaxo Group Limited Novel Compounds
TW200724142A (en) 2005-03-25 2007-07-01 Glaxo Group Ltd Novel compounds
KR20080002865A (ko) 2005-03-25 2008-01-04 글락소 그룹 리미티드 피리도[2,3-d]피리미딘-7-온 및3,4-디히드로피리미도[4,5-d]피리미딘-2(1h)-온유도체의 제조 방법
CN101300232A (zh) * 2005-07-26 2008-11-05 默克公司 合成取代的吡唑的方法
EP1992344A1 (fr) 2007-05-18 2008-11-19 Institut Curie P38 alpha comme cible therapeutique pour les maladies associées á une mutation de FGFR3
US20110195962A1 (en) * 2007-08-16 2011-08-11 Alcon Research, Ltd. Use of multi-pharmacophore compounds to treat nasal disorders
WO2009039387A1 (fr) * 2007-09-20 2009-03-26 Wyeth Pyrazolo[5,1-c]-[1,2,4]-triazines et leurs procédés de préparation et d'utilisation
CN101441969B (zh) 2007-11-23 2010-07-28 清华大学 场发射像素管
CN101441972B (zh) 2007-11-23 2011-01-26 鸿富锦精密工业(深圳)有限公司 场发射像素管
EP2402344A1 (fr) * 2010-06-29 2012-01-04 Basf Se Dérivés de pyrazole bicycliques condensés

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992012154A1 (fr) * 1990-12-31 1992-07-23 Fujisawa Pharmaceutical Co., Ltd. Derive d'immidazotriazine
US5356897A (en) * 1991-09-09 1994-10-18 Fujisawa Pharmaceutical Co., Ltd. 3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines

Also Published As

Publication number Publication date
TW260669B (fr) 1995-10-21
WO1994019350A1 (fr) 1994-09-01
CA2156919A1 (fr) 1994-09-01
AU6010894A (en) 1994-09-14
IL108562A0 (en) 1994-05-30
GB9303993D0 (en) 1993-04-14
HU9402459D0 (en) 1994-11-28
EP0686156A1 (fr) 1995-12-13
KR100313615B1 (ko) 2002-05-30
CN1120840A (zh) 1996-04-17
JP3569917B2 (ja) 2004-09-29
EP0686156B1 (fr) 2002-07-17
US5670503A (en) 1997-09-23
KR960701055A (ko) 1996-02-24
ZA94787B (en) 1994-09-08
JPH08507056A (ja) 1996-07-30
IL108562A (en) 1997-06-10
DE69430988D1 (de) 2002-08-22
CN1041929C (zh) 1999-02-03
PT686156E (pt) 2002-12-31
RU2124517C1 (ru) 1999-01-10
ES2176235T3 (es) 2002-12-01
HUT70832A (en) 1995-11-28
MX9401408A (es) 1994-08-31
AU681625B2 (en) 1997-09-04
DE69430988T2 (de) 2002-11-28
ATE220677T1 (de) 2002-08-15

Similar Documents

Publication Publication Date Title
DK0686156T3 (da) Pyrazoltriaziner med inhiberende aktivitet over for interleukin-1 og tumornekrosefaktor
GR3036549T3 (en) GUANIDINE DERIVATIVES AS INHIBITORS OF Na+ /H+ EXCHANGE IN CELLS
MX9700308A (es) Derivados heterobiciclicos.
GR3034542T3 (en) 4,5-diaryloxazole derivatives
MX9800577A (es) Derivados de 4,5-diaril oxazol.
ATE195117T1 (de) 1-amdinophenyl-pyrrolidone/piperidinone als blutblättchen-aggregations inhibitoren
NO971470D0 (no) Nye pyrimidon-derivater med fungicid aktivitet
EP0628311A4 (fr) Antidepresseur.
AU1070895A (en) Indole-derived arylpiperazines as ligands for 5HT1-like receptors 5HT1B and 5HT1D
GB9602029D0 (en) New heterocyclic compounds
DK0572635T3 (da) Hidtil ukendte forbindelser med guanidinstruktur og farmaceutisk komposition indeholdende forbindelserne
HUP0103303A2 (hu) Imidazolvegyületek, eljárás előállításukra, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
GB9313330D0 (en) New compound and its preparation
ATE234818T1 (de) Chinolinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
AU7467694A (en) Pyridazinone derivatives or their salts, processes for theirproduction, and anti-shock agents containing them
ATE255102T1 (de) Benzothiophenderivate, ihre herstellung und verwendung als urokinase-inhibitoren
DK0544748T3 (da) Spiro cycloalkylbenzen-1, 1-(1,2,3,4-tetrahydroisoquinoliner) med neurobeskyttende egenskaber